Pages that link to "Q41485356"
Jump to navigation
Jump to search
The following pages link to Jason S. Lewis (Q41485356):
Displaying 50 items.
- Improved Upper Limits on the Stochastic Gravitational-Wave Background from 2009–2010 LIGO and Virgo Data (Q21706450) (← links)
- Search for Gravitational Waves Associated with γ -ray Bursts Detected by the Interplanetary Network (Q21706456) (← links)
- Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET (Q24633858) (← links)
- Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome (Q27318509) (← links)
- Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 (Q28249103) (← links)
- Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes (Q28384090) (← links)
- Advanced LIGO (Q30050565) (← links)
- Cerenkov luminescence imaging of medical isotopes (Q30499280) (← links)
- Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET (Q30643770) (← links)
- Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy (Q33335764) (← links)
- Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab (Q33527397) (← links)
- Standardized methods for the production of high specific-activity zirconium-89. (Q33685309) (← links)
- Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. (Q33812606) (← links)
- Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal [...] (Q33995700) (← links)
- Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals (Q34119201) (← links)
- 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. (Q34389457) (← links)
- Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives (Q34473460) (← links)
- Small animal imaging. current technology and perspectives for oncological imaging (Q34975027) (← links)
- Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging (Q35040549) (← links)
- Haemophilus influenzae Type b Carriage and Novel Bacterial Population Structure among Children in Urban Kathmandu, Nepal (Q35066923) (← links)
- The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer. (Q35133494) (← links)
- The next generation of positron emission tomography radiopharmaceuticals in oncology. (Q35525690) (← links)
- Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU). (Q35541289) (← links)
- A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy (Q35544056) (← links)
- Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia. (Q35545523) (← links)
- Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes. (Q35565660) (← links)
- Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo (Q35606075) (← links)
- Fully-automated synthesis of 16β-(18)F-fluoro-5α-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer. (Q35931391) (← links)
- Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. (Q35956405) (← links)
- Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. (Q36418274) (← links)
- Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. (Q36435260) (← links)
- PET imaging with ⁸⁹Zr: from radiochemistry to the clinic (Q36454584) (← links)
- PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles (Q36533549) (← links)
- Applying ⁸⁹Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins. (Q36536355) (← links)
- Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma. (Q36580750) (← links)
- (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer (Q36625800) (← links)
- Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71. (Q36654876) (← links)
- Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review (Q36707388) (← links)
- Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses (Q36855892) (← links)
- Antilipolytic drug boosts glucose metabolism in prostate cancer. (Q36871763) (← links)
- Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. (Q37024507) (← links)
- Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies (Q37033947) (← links)
- Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin. (Q37049634) (← links)
- Imaging tumor burden in the brain with 89Zr-transferrin (Q37106244) (← links)
- Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy (Q37114081) (← links)
- Clickable bifunctional radiometal chelates for peptide labeling (Q37120660) (← links)
- Influence of free fatty acids on glucose uptake in prostate cancer cells (Q37122861) (← links)
- Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis. (Q37122878) (← links)
- Copper-64 Radiopharmaceuticals for Oncologic Imaging (Q37126530) (← links)
- In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice. (Q37129823) (← links)